Finance

Lists
INDGN:NSE
Indegene Ltd
598,45 INR
+1,23%
(+7,25) 1D
16-окт., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for INDGN...
Open
588,80 INR
High
600,00 INR
Low
584,20 INR
Mkt. cap
144,21 млд
Avg. vol.
446,78 миң
Volume
167,20 миң
Dividend
0,38%
Quarterly dividend
0,56 INR
Ex-dividend date
2026-ж., 31-июл.
P/E ratio
36,01
52-wk high
627,00 INR
52-wk low
414,00 INR
EPS
16,62 INR
No. of employees
5 миң
Open
588,80 INR
High
600,00 INR
Low
584,20 INR
Mkt. cap
144,21 млд
Avg. vol.
446,78 миң
Volume
167,20 миң
Dividend
0,38%
Quarterly dividend
0,56 INR
Ex-dividend date
2026-ж., 31-июл.
P/E ratio
36,01
52-wk high
627,00 INR
52-wk low
414,00 INR
EPS
16,62 INR
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
About Indegene Ltd
CEOManish Gupta
Employees4,69 миң
Founded1998
Headquarters-
SectorHealth care
Next call 12 күндөн кийин
30-окт., жума, 04:30
Fiscal period
Q2 2027
- / 4,63 INR
Revenue / Est. (INR)
- / 11,04 млд
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
8,04 млд
9,42 млд
10,03 млд
10,63 млд
Cost of goods sold
-
-
778,00 млн
-
Cost of revenue
-
-
778,00 млн
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,16 млд
5,68 млд
6,39 млд
6,59 млд
Operating expense
6,87 млд
8,22 млд
7,99 млд
9,33 млд
Total operating expenses
6,87 млд
8,22 млд
8,77 млд
9,33 млд
Operating income
1,17 млд
1,20 млд
1,26 млд
1,30 млд
Other non operating income
197,00 млн
194,00 млн
-620,00 млн
290,00 млн
EBT including unusual items
1,33 млд
1,35 млд
1,05 млд
1,53 млд
EBT excluding unusual items
1,33 млд
1,35 млд
944,00 млн
1,53 млд
Income tax expense
310,00 млн
318,00 млн
254,00 млн
365,00 млн
Effective tax rate
23,29%
23,61%
24,17%
23,90%
Other operating expenses
1,48 млд
2,15 млд
1,18 млд
2,30 млд
Net income
1,02 млд
1,03 млд
797,00 млн
1,16 млд
Net profit margin
12,70%
10,92%
7,94%
10,93%
Earnings per share
4,23
4,26
3,94
4,81
Interest and investment income
-
-
363,00 млн
-
Interest expense
-38,00 млн
-46,00 млн
-39,00 млн
-64,00 млн
Net interest expenses
-38,00 млн
-46,00 млн
324,00 млн
-64,00 млн
Depreciation and amortization charges
234,00 млн
396,00 млн
418,00 млн
441,00 млн
EBITDA
1,40 млд
1,33 млд
1,49 млд
1,53 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору